rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Randal J. Kirk

Director and 10% owner

Company insider

Files Form 4 as: Executive Chairman, Precigen; 10% owner, AquaBounty Technologies; Director and 10% owner, Alaunos Therapeutics; 10% owner, Precipio; Director and 10% owner, Halozyme Therapeutics; 10% owner, Soligenix; 10% owner, Fibrocell Science; 10% owner, Armata Pharmaceuticals.

Every Form 4 they filed

In numbers

Trades disclosed
1,216
Buys
147
Sells
37
Bought
$545.9M
Sold
$173.0M
Companies
12
Companies where not an officer
10
First trade
9 Feb 2006
Last trade
30 Mar 2026
Last filed
31 Mar 2026

Companies traded

Where they are an officer
PGEN PrecigenDirector, Officer, 10% owner · Biotechnology · last 30 Mar 202659 buys · 8 sells
New River PharmaceuticalsDirector, Officer, 10% owner · last 25 Jan 20070 buys · 2 sells
Everywhere else they filed: board seats, 10% stakes, other companies
AQB AquaBounty Technologies10% owner · Agriculture & Farm Products · last 23 Nov 20212 buys · 1 sell
TCRT Alaunos TherapeuticsDirector, 10% owner · Biotechnology · last 5 Oct 20186 buys · 0 sells
HALO Halozyme TherapeuticsDirector, 10% owner · Biotechnology · last 28 Aug 201859 buys · 18 sells
PRPO Precipio10% owner · Life-science tools · last 28 Aug 20182 buys · 2 sells
SNGX Soligenix10% owner · Biotechnology · last 8 May 20170 buys · 3 sells
Fibrocell Science10% owner · last 8 Mar 20175 buys · 0 sells
ARMP Armata Pharmaceuticals10% owner · Biotechnology · last 29 Dec 20160 buys · 3 sells
OGEN Oragenics10% owner · Biotechnology · last 1 Dec 20151 buy · 0 sells
TOVX Theriva Biologics10% owner · Biotechnology · last 2 Sep 20152 buys · 0 sells
Clinical DataDirector, 10% owner · last 12 Apr 201111 buys · 0 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
30Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
30 Mar 2026filed 31 Mar 2026PGEN PrecigenBiotechnologySEC FORM 4 Sold$3.7M1,108,998 at $3.30filing
30 Mar 2026filed 31 Mar 2026PGEN PrecigenBiotechnologySEC FORM 4 Sold$79K23,789 at $3.30filing
30 Mar 2026filed 31 Mar 2026PGEN PrecigenBiotechnologySEC FORM 4 Sold$7.7M2,334,420 at $3.30filing
30 Mar 2026filed 31 Mar 2026PGEN PrecigenBiotechnologySEC FORM 4 Sold$168K50,797 at $3.30filing
30 Mar 2026filed 31 Mar 2026PGEN PrecigenBiotechnologySEC FORM 4 Sold$1.2M370,847 at $3.30filing
30 Mar 2026filed 31 Mar 2026PGEN PrecigenBiotechnologySEC FORM 4 Sold$502K152,063 at $3.30filing
30 Mar 2026filed 31 Mar 2026PGEN PrecigenBiotechnologySEC FORM 4 Sold$168K50,797 at $3.30filing
30 Mar 2026filed 31 Mar 2026PGEN PrecigenBiotechnologySEC FORM 4 Sold$1.4M426,199 at $3.30filing
30 Mar 2026filed 31 Mar 2026PGEN PrecigenBiotechnologySEC FORM 4 Sold$557K168,794 at $3.30filing
30 Mar 2026filed 31 Mar 2026PGEN PrecigenBiotechnologySEC FORM 4 Sold$155K47,101 at $3.30filing
30 Mar 2026filed 31 Mar 2026PGEN PrecigenBiotechnologySEC FORM 4 Sold$3.7M1,108,998 at $3.30filing
30 Mar 2026filed 31 Mar 2026PGEN PrecigenBiotechnologySEC FORM 4 Sold$168K50,797 at $3.30filing
30 Mar 2026filed 31 Mar 2026PGEN PrecigenBiotechnologySEC FORM 4 Sold$1.2M370,847 at $3.30filing
30 Mar 2026filed 31 Mar 2026PGEN PrecigenBiotechnologySEC FORM 4 Sold$502K152,063 at $3.30filing
30 Mar 2026filed 31 Mar 2026PGEN PrecigenBiotechnologySEC FORM 4 Sold$168K50,797 at $3.30filing
30 Mar 2026filed 31 Mar 2026PGEN PrecigenBiotechnologySEC FORM 4 Sold$1.4M426,199 at $3.30filing
30 Mar 2026filed 31 Mar 2026PGEN PrecigenBiotechnologySEC FORM 4 Sold$557K168,794 at $3.30filing
30 Mar 2026filed 31 Mar 2026PGEN PrecigenBiotechnologySEC FORM 4 Sold$155K47,101 at $3.30filing
30 Mar 2026filed 31 Mar 2026PGEN PrecigenBiotechnologySEC FORM 4 Sold$129K38,976 at $3.30filing
30 Mar 2026filed 31 Mar 2026PGEN PrecigenBiotechnologySEC FORM 4 Sold$79K23,789 at $3.30filing

The newest 500 lines are listed; the numbers count every line.

News

No headline names them, or the companies they trade most, lately.

Sectors

Health Care163
Consumer Staples3
Not placed18

Buys in green, sells in red, by the company’s sector.

Related people

Harry Thomasian Jr.Chief Financial Officer · Chief Financial Officer at Precigen, filing Form 4 there in the last year
Jeffrey B. KindlerDirector · Director at Precigen, filing Form 4 there in the last year
Phil TennantChief Commercial Officer · Chief Commercial Officer at Precigen, filing Form 4 there in the last year
Donald P. LehrChief Legal Officer · Chief Legal Officer at Precigen, filing Form 4 there in the last year
Nancy H. AgeeDirector · Director at Precigen, filing Form 4 there in the last year
Helen TorleyPresident and CEO · Also traded HALO in the last 90 days
Matthew L. PosardDirector · Also traded HALO in the last 90 days
Gilbert Ray Cisneros, Jr.Representative, CA-31 · Also traded HALO in the last 90 days